Israeli company Life Wave appears to be gaining momentum in the market with their medical device for treating bed sores (pictured right). According to Globes online, the company has signed two new European distributors. Bed sores are one of the 13 preventable hospital-acquired conditions that for which CMS will stop paying hospitals to treat in 2008 (more here).

Each distributor will have exclusive marketing rights in their countries for LifeWave’s BST and disposable electrodes.

company said that with these two new deals, it now has exclusive
marketing agreements with five distributors in five European countries.

Since hospitals will be on the hook for any costs related to treating preventable bed sores, any device that proves cost effective in treating bed sores should do quite well in the U.S.

At right is the Life Wave device and disposable electrodes.